Raymond James Maintains Outperform on AngioDynamics, Lowers Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford has maintained an Outperform rating on AngioDynamics (NASDAQ:ANGO) but lowered the price target from $13 to $12.

October 06, 2023 | 8:16 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AngioDynamics' price target has been lowered from $13 to $12 by Raymond James, though the Outperform rating is maintained.
The lowering of the price target by Raymond James could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained Outperform rating indicates that the analyst still sees potential upside, which could counterbalance the negative impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100